Advertisement
Research General gynecology| Volume 201, ISSUE 3, P263.e1-263.e9, September 2009

Oral contraceptive effectiveness according to body mass index, weight, age, and other factors

      Objective

      The purpose of this study was to assess the use-effectiveness of oral contraceptives (OCs) in Europe according to body mass index (BMI), weight, age, and other factors.

      Study Design

      In a planned secondary analysis, we used data from the European Active Surveillance Study on Oral Contraceptives, which was a prospective active cohort surveillance study of 59,510 OC users, to assess the effectiveness of OCs overall and by BMI, weight, age, duration of use, ethinylestradiol dose, regimen type, starting/switching status, and parity. Self-reported unplanned pregnancies during OC use were confirmed by interview.

      Results

      An analysis of OC effectiveness (112,659 women-years of exposure and 545 unplanned pregnancies) found little variation in effectiveness by BMI/weight. Failure rates decreased after 30 years of age and with an increasing duration of use.

      Conclusion

      OC users in Europe reported high contraceptive effectiveness with “typical use.” Failure rates decreased with age and duration of use. BMI and weight had little, if any, influence on effectiveness.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Trussell J.
        Contraceptive efficacy.
        in: Hatcher R.A. Trussell J. Nelson A.L. Cates W. Stewart F.H. Kowal D. Contraceptive technology. 18th ed. Ardent Media, New York2007: 792
        • Food and Drug Administration
        Transcript: Advisory Committee for Reproductive Health Drugs, January 24, 2007.
        (Accessed Jan. 7, 2009)
        • Brunner Huber L.R.
        • Hogue C.J.
        The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception.
        Matern Child Health J. 2005; 9: 413-420
        • Holt V.L.
        • Cushing-Haugen K.L.
        • Daling J.R.
        Body weight and risk of oral contraceptive failure.
        Obstet Gynecol. 2002; 99: 820-827
        • Holt V.L.
        • Scholes D.
        • Wicklund K.G.
        • Cushing-Haugen K.L.
        • Daling J.R.
        Body mass index, weight, and oral contraceptive failure risk.
        Obstet Gynecol. 2005; 105: 46-52
        • Brunner Huber L.R.
        • Hogue C.J.
        • Stein A.D.
        • Drews C.
        • Zieman M.
        Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina.
        Ann Epidemiol. 2006; 16: 637-643
        • Brunner Huber L.R.
        • Toth J.L.
        Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth.
        Am J Epidemiol. 2007; 166: 1306-1311
        • Brunner L.R.
        • Hogue C.J.
        The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth.
        Ann Epidemiol. 2005; 15: 492-499
        • Vessey M.
        Oral contraceptive failures and body weight: findings in a large cohort study.
        J Fam Plann Reprod Health Care. 2001; 27: 90-91
        • Dinger J.C.
        • Heinemann L.A.J.
        • Kühl-Habich D.
        The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation.
        Contraception. 2007; 75: 344-354
        • European Medicines Agency Committee for Medicinal Products for Human Use
        Guideline on clinical investigation of steroid contraceptives in women, July 27, 2005.
        (Accessed Jan. 6, 2009)
        • Gerlinger C.
        • Endrikat J.
        • van der Meulen E.A.
        • Dieben T.O.
        • Dusterberg B.
        Recommendation for confidence interval and sample size calculation for the Pearl Index.
        Eur J Contracept Reprod Health Care. 2003; 8: 87-92
        • Gallegos A.J.
        • Gonzáles-Diddi M.
        • Merino G.
        • Martínez-Manautou J.
        Tissue localization of radioactive chlormadinone acetate and progesterone in the human.
        Contraception. 1970; 1: 151-161
        • Hamilton B.E.
        • Sutton P.D.
        • Ventura S.J.
        Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States.
        Natl Vital Stat Rep. 2003; 51: 1-94
        • Larsen U.
        • Yan S.
        The age pattern of fecundability: an analysis of French Canadian and Hutterite birth histories.
        Soc Biol. 2000; 47: 34-50
        • Wood J.W.
        Fecundity and natural fertility in humans.
        Oxf Rev Reprod Biol. 1989; 11: 61-109
        • Cronin M.
        • Möhner S.
        • Minh Thai D.
        • Westhoff C.
        Past oral contraception use does not negatively affect time to conception.
        Obstet Gynecol. 2007; 109: 3S
        • Trussell J.
        Methodological pitfalls in the analysis of contraceptive failure.
        Stat Med. 1991; 10: 201-220
        • Howe G.
        • Westhoff C.
        • Vessey M.
        • Yeates D.
        Effects of age, cigarette smoking, and other factors on fertility: findings in a large prospective study.
        Br Med J (Clin Res Ed). 1985; 290: 1697-1700
        • Cronin M.
        • Möhner S.
        • Dinger J.
        • Schellschmidt I.
        Return to fertility after use of oral contraceptives: results from the EURAS study.
        in: Proceedings of the 9th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Barcelona, Spain, March 22-25, 20072007 (A-68)
        • Nyholm M.
        • Gullberg B.
        • Merlo J.
        • Lundqvist-Persson C.
        • Rastam L.
        • Lindblad U.
        The validity of obesity based on self-reported weight and height: Implications for population studies.
        Obesity (Silver Spring). 2007; 15: 197-208
        • Visscher T.L.
        • Viet A.L.
        • Kroesbergen I.H.
        • Seidell J.C.
        Underreporting of BMI in adults and its effect on obesity prevalence estimations in the period 1998 to 2001.
        Obesity (Silver Spring). 2006; 14: 2054-2063
        • Kost K.
        • Singh S.
        • Vaughan B.
        • Trussell J.
        • Bankole A.
        Estimates of contraceptive failure from the 2002 National Survey of Family Growth.
        Contraception. 2008; 77: 10-21
        • Darney P.
        Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials.
        Contraception. 1993; 48: 323-337
        • Ferguson H.
        • Vree M.L.
        • Wilpshaar J.
        • Eskes T.K.
        Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive.
        Eur J Contracept Reprod Health Care. 2000; 5: 35-45
        • Grubb G.S.
        • Archer D.F.
        • Constantine G.D.
        Differences between the United States and Europe in clinical trials of hormonal contraceptive efficacy.
        Obstet Gynecol. 2008; 111: 63S
        • Salas M.
        • Kiefe C.I.
        • Schreiner P.J.
        • et al.
        Obesity modifies the association of race/ethnicity with medication adherence in the CARDIA study.
        The Patient. 2008; 1: 41-54

      Linked Article

      • Factors influencing oral contraceptive effectiveness: Dinger et al
        American Journal of Obstetrics & GynecologyVol. 201Issue 3
        • Preview
          The article below summarizes a roundtable discussion of a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed: Dinger JC, Cronin M, Möhner S, et al. Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol 2009;201:263.e1-9. The full discussion appears at www.AJOG.org , pages e1-4.
        • Full-Text
        • PDF
      • Discussion: ‘Factors influencing oral contraceptive effectiveness’ by Dinger et al
        American Journal of Obstetrics & GynecologyVol. 201Issue 3
        • Preview
          In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed: Dinger JC, Cronin M, Möhner S, et al. Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol 2009;201:263.e1-9.
        • Full-Text
        • PDF